Asian Spectator

Jemincare group has completed the Phase I clinical trial of it...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
SHANGHAI, Sept. 14, 2021 /PRNewswire-AsiaNet/ -- Recently, Jemincare group has declared that it has completed phase I clinical trial of self-developed novel coronavirus specific neutralizing antibody (Project code: JMB2002). The clinical trial of JMB2002 was stated in January 2021. A single-...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

5 evaluasi atas program bendungan era Jokowi

Presiden RI Joko Widodo (Jokowi) meresmikan Bendungan Pamukkulu, di Kabupaten Takalar, Provinsi Sulawesi Selatan.(Muchlis Jr/BPMI Setpres)Prabowo-Gibran, yang pencalonannya sebagai Presiden dan Wakil ...

Benarkah goresan kecil di tubuh bisa mematikan di masa depan? Ini kata pakar resistansi antibiotik

Ilustrasi luka gores pada jari seorang perempuan. Timofeyev Alexander/ShutterstockArtikel ini diterjemahkan dari bahasa Inggris untuk memperingati Pekan Kesadaran Antimikroba Dunia, 18-24 November.Ber...

Why Now Is the Perfect Time to Lease an Electric Vehicle?

Australia is seeing strong year on year growth of EVs, with government incentives, advancements in technology, and environmental awareness driving more people to consider electric vehicles. If you’ve...



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion